Cardinal Health, Inc.
CAH
$98.91
-$4.07-3.95%
| Weiss Ratings | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | A- | |||
| Rating Factors | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.53 | |||
| Price History | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.11% | |||
| 30-Day Total Return | -6.14% | |||
| 60-Day Total Return | -5.50% | |||
| 90-Day Total Return | 2.73% | |||
| Year to Date Total Return | 0.58% | |||
| 1-Year Total Return | 28.98% | |||
| 2-Year Total Return | 73.85% | |||
| 3-Year Total Return | 77.02% | |||
| 5-Year Total Return | 138.01% | |||
| 52-Week High % Change | -10.54% | |||
| 52-Week Low % Change | 33.84% | |||
| Price | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $116.04 | |||
| 52-Week Low Price | $77.56 | |||
| 52-Week Low Price (Date) | May 04, 2023 | |||
| 52-Week High Price (Date) | Mar 13, 2024 | |||
| Valuation | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 26.32B | |||
| Enterprise Value | 26.45B | |||
| Price/Earnings (TTM) | 42.63 | |||
| Earnings Per Share (TTM) | 2.54 | |||
| Earnings Per Share Growth | -154.54% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.12 | |||
| Price/Book (Q) | -7.65 | |||
| Enterprise Value/Revenue (TTM) | 0.12 | |||
| Price | $103.21 | |||
| Enterprise Value/EBITDA (TTM) | 9.30 | |||
| Enterprise Value/EBIT | 12.50 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 246.00M | |||
| Dividend Yield | 1.85% | |||
| Div. Per Share (Most Recent) | $0.50 | |||
| Dividend Per Share (TTM) | $2.00 | |||
| Payout Ratio (TTM) | 79.66% | |||
| Dividend Per Share (Most Recent) | $0.50 | |||
| Company Info | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 614 757 5000 | |||
| Address | 7000 Cardinal Place Dublin, OH 43017 | |||
| Website | www.cardinalhealth.com | |||
| Country | United States | |||
| Year Founded | 1979 | |||
| Profitability | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.93% | |||
| Profit Margin | 0.29% | |||
| Management Effectiveness | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.79% | |||
| Return on Equity | -- | |||
| Income Statement | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 216.15B | |||
| Total Revenue (TTM) | 216.15B | |||
| Revenue Per Share | $878.65 | |||
| Gross Profit (TTM) | 7.23B | |||
| EBITDA (TTM) | 2.73B | |||
| EBIT (TTM) | 2.03B | |||
| Net Income (TTM) | 639.00M | |||
| Net Income Avl. to Common (TTM) | 639.00M | |||
| Total Revenue Growth (Q YOY) | 11.61% | |||
| Earnings Growth (Q YOY) | 372.31% | |||
| EPS Diluted (TTM) | 2.54 | |||
| EPS Diluted Growth (Q YOY) | 386.00% | |||
| Balance Sheet | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.59B | |||
| Cash Per Share (Q) | $18.66 | |||
| Total Current Assets (Q) | 37.66B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -3.45B | |||
| Current Ratio (Q) | 0.984 | |||
| Book Value Per Share (Q) | -$14.14 | |||
| Total Assets (Q) | 46.57B | |||
| Total Current Liabilities (Q) | 38.29B | |||
| Total Debt (Q) | 4.72B | |||
| Total Liabilities (Q) | 50.02B | |||
| Total Common Equity (Q) | -3.45B | |||
| Cash Flow | CAH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -465.00M | |||
| Cash from Financing (TTM) | -2.55B | |||
| Net Change in Cash (TTM) | 937.00M | |||
| Levered Free Cash Flow (TTM) | 3.84B | |||
| Cash from Operations (TTM) | 3.95B | |||
